BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33211143)

  • 1. Bladder cancer: do we need contrast injection for MRI assessment of muscle invasion? A prospective multi-reader VI-RADS approach.
    Delli Pizzi A; Mastrodicasa D; Marchioni M; Primiceri G; Di Fabio F; Cianci R; Seccia B; Sessa B; Mincuzzi E; Romanelli M; Castellan P; Castellucci R; Colasante A; Schips L; Basilico R; Caulo M
    Eur Radiol; 2021 Jun; 31(6):3874-3883. PubMed ID: 33211143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of biparametric vs multiparametric MRI in clinically significant prostate cancer: Comparison between readers with different experience.
    Di Campli E; Delli Pizzi A; Seccia B; Cianci R; d'Annibale M; Colasante A; Cinalli S; Castellan P; Navarra R; Iantorno R; Gabrielli D; Buffone A; Caulo M; Basilico R
    Eur J Radiol; 2018 Apr; 101():17-23. PubMed ID: 29571792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesical Imaging Reporting and Data System (VI-RADS): Are the individual MRI sequences equivalent in diagnostic performance of high grade NMIBC and MIBC?
    Gmeiner J; Garstka N; Helbich TH; Shariat SF; Baltzer PA
    Eur J Radiol; 2021 Sep; 142():109829. PubMed ID: 34252867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of multiparametric MRI in predicting muscle invasiveness in urinary bladder neoplasms with pathological correlations.
    Tandon M; Chakraborty S; Barkondaj B; Choudhury S; Pal DK
    Urologia; 2024 Feb; 91(1):55-60. PubMed ID: 37886848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical utility of the Vesical Imaging-Reporting and Data System for muscle-invasive bladder cancer between radiologists and urologists based on multiparametric MRI including 3D FSE T2-weighted acquisitions.
    Arita Y; Shigeta K; Akita H; Suzuki T; Kufukihara R; Kwee TC; Ishii R; Mikami S; Okuda S; Kikuchi E; Oya M; Jinzaki M
    Eur Radiol; 2021 Feb; 31(2):875-883. PubMed ID: 32829418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
    Makboul M; Farghaly S; Abdelkawi IF
    Br J Radiol; 2019 Dec; 92(1104):20190401. PubMed ID: 31573328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiparametric MRI of the bladder: inter-observer agreement and accuracy with the Vesical Imaging-Reporting and Data System (VI-RADS) at a single reference center.
    Barchetti G; Simone G; Ceravolo I; Salvo V; Campa R; Del Giudice F; De Berardinis E; Buccilli D; Catalano C; Gallucci M; Catto JWF; Panebianco V
    Eur Radiol; 2019 Oct; 29(10):5498-5506. PubMed ID: 30887202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Biparametric and Multiparametric MRI for Clinically Significant Prostate Cancer Detection With PI-RADS Version 2.1.
    Tamada T; Kido A; Yamamoto A; Takeuchi M; Miyaji Y; Moriya T; Sone T
    J Magn Reson Imaging; 2021 Jan; 53(1):283-291. PubMed ID: 32614123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visual MRI T-category versus VI-RADS evaluation from multiparametric MRI in the detection of muscle-invasion in patients with suspected bladder cancer: single centre registered clinical trial (MIB-trial).
    Nikulainen I; Salminen AP; Jambor I; Merisaari H; Tammilehto V; Taimen P; Seikkula H; Boström PJ
    Scand J Urol; 2021 Oct; 55(5):354-360. PubMed ID: 34448679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detecting Muscle Invasion of Bladder Cancer Using a Proposed Magnetic Resonance Imaging Strategy.
    Wang X; Tu N; Sun F; Wen Z; Lan X; Lei Y; Cui E; Lin F
    J Magn Reson Imaging; 2021 Oct; 54(4):1212-1221. PubMed ID: 33998725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic benefit of multiparametric MRI over contrast-enhanced CT in patients with bladder cancer: A single-center 1-year experience.
    Hagen F; Norz V; Thaiss WM; Mair A; Rausch S; Bedke J; Nikolaou K; Stenzl A; Kruck S; Hepp T; Kaufmann S; Estler A
    Eur J Radiol; 2022 Jan; 146():110059. PubMed ID: 34839167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study.
    Ueno Y; Tamada T; Takeuchi M; Sofue K; Takahashi S; Kamishima Y; Urase Y; Kido A; Hinata N; Harada K; Fujisawa M; Miyaji Y; Murakami T
    AJR Am J Roentgenol; 2021 May; 216(5):1257-1266. PubMed ID: 32755215
    [No Abstract]   [Full Text] [Related]  

  • 13. Optimized MRI Assessment for Clinically Significant Prostate Cancer: A STARD-Compliant Two-Center Study.
    Bao J; Zhi R; Hou Y; Zhang J; Wu CJ; Wang XM; Zhang YD
    J Magn Reson Imaging; 2021 Apr; 53(4):1210-1219. PubMed ID: 33075177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesical Imaging-Reporting and Data System for Multiparametric MRI to Predict the Presence of Muscle Invasion for Bladder Cancer.
    Hong SB; Lee NK; Kim S; Son IW; Ha HK; Ku JY; Kim KH; Park WY
    J Magn Reson Imaging; 2020 Oct; 52(4):1249-1256. PubMed ID: 32220105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Accuracy and Interobserver Agreement for the Vesical Imaging-Reporting and Data System for Muscle-invasive Bladder Cancer: A Multireader Validation Study.
    Ueno Y; Takeuchi M; Tamada T; Sofue K; Takahashi S; Kamishima Y; Hinata N; Harada K; Fujisawa M; Murakami T
    Eur Urol; 2019 Jul; 76(1):54-56. PubMed ID: 30922688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)-do we still need contrast media?
    Huebner NA; Korn S; Resch I; Grubmüller B; Gross T; Gale R; Kramer G; Poetsch N; Clauser P; Haitel A; Fajkovic H; Shariat SF; Baltzer PA
    Eur Radiol; 2021 Jun; 31(6):3754-3764. PubMed ID: 33263793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biparametric 3T Magnetic Resonance Imaging for prostatic cancer detection in a biopsy-naïve patient population: a further improvement of PI-RADS v2?
    Stanzione A; Imbriaco M; Cocozza S; Fusco F; Rusconi G; Nappi C; Mirone V; Mangiapia F; Brunetti A; Ragozzino A; Longo N
    Eur J Radiol; 2016 Dec; 85(12):2269-2274. PubMed ID: 27842676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VI-RADS score and tumor contact length in MRI: A potential method for the detection of muscle invasion in bladder cancer.
    Akcay A; Yagci AB; Celen S; Ozlulerden Y; Turk NS; Ufuk F
    Clin Imaging; 2021 Sep; 77():25-36. PubMed ID: 33639497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Added value of diffusion-weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial.
    Eldred-Evans D; Neves JB; Simmons LAM; Kanthabalan A; McCartan N; Shah TT; Arya M; Charman SC; Freeman A; Moore CM; Punwani S; Emberton M; Ahmed HU
    BJU Int; 2020 Mar; 125(3):391-398. PubMed ID: 31733173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.